News
(AP) — KALA BIO, Inc. (KALA) on Monday reported a loss of $8.2 million in its fourth quarter. The Arlington, Massachusetts-based company said it had a loss of $1.74 per share. For the year ...
12d
Randomized 87 patients to date in Phase 2b CHASE trial of KPI-012 in Persistent Corneal Epithelial Defect (PCED) ---- Continuing enrollment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback